Clinical Trial Update: A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating canakinumab with chemotherapy, radiation therapy, and durvalumab for non-small cell lung cancer; the study is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Canakinumab (Ilaris) (canakinumab)
• Durvalumab (durvalumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING